ProjectPTC 743-Neu-003e-FA – A randomized, parallel-arm, double-blind, placebo-controlled Study with open-label extension…
Basic data
Acronym:
PTC 743-Neu-003e-FA
Title:
A randomized, parallel-arm, double-blind, placebo-controlled Study with open-label extension to assess the safety and efficacy of Vatiquinone for the treatment of Friedreich Ataxia
Duration:
01/03/2023 to 31/12/2027
Abstract / short description:
A randomized, parallel-arm, double-blind, placebo-controlled Study with open-label extension to assess the safety and efficacy of Vatiquinone for the treatment of Friedreich Ataxia
Keywords:
ataxia
Ataxie
Vatiquinone
Friedreich Ataxie
kontrollierte Studie
Phase 3 Studie
PTC
Involved staff
Managers
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Neurology with Focus on Neurodegenerative Disorders
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Plainfield, New Jersey, United States